In a new study from Penn Medicine, researchers found that taller people have an increased risk of developing atrial fibrillation (AFib), an irregular and often rapid heartbeat that can lead to stroke, heart failure and other complications.
They found a strong link between the genetic variants associated with height and one’s risk for AFib, is the among the first to demonstrate that height may be a causal—not correlated—risk factor for AFib.
AFib, which affects more than 33 million people worldwide, is a common, abnormal heart rhythm.
There are a number of clinical risk factors for developing AFib, including high blood pressure, heart disease, diabetes, and obesity.
Previous studies have found that taller individuals appear to have a higher risk of developing AFib. However, questions exist about whether height can cause AFib, or if it’s just a common, insignificant factor.
In the study, the team used data from the Genetic Investigation of Anthropometric Trials (GIANT) consortium, which studied more than 700,000 individuals to identify genetic variants associated with height.
They also examined data from the Atrial Fibrillation Genetics (AFGen) consortium, which studied more than 500,000 individuals to identify genetic variants associated with AFib.
They found that the risk for AFib climbed as one’s height increased, with every one-inch increase in height translating to about a 3% increase in risk of Afib—independent of other clinical factors—as compared to those at average height (5 feet and 7 inches).
Their analysis revealed that genetic variants associated with height were also strongly associated with Afib, suggesting that increased height may be a cause of atrial fibrillation.
This link remained strong even after adjusting for traditional AFib risk factors, like heart disease, high blood pressure, and diabetes, among others.
The team also found that height, and genetic variants associated with height, are strongly associated with an increased risk of AFib, independent from traditional clinical and echocardiographic risk factors.
While current guidelines advise against widespread screening for AFib, these findings show that a certain group of patients—specifically, very tall patients—may benefit from screening.
If you care about heart health, please read studies about this health problem in middle-age may predict heart failure later in life and findings of this number, not BMI, linked to heart disease in people with diabetes.
For more information about heart disease prevention and treatment, please see recent studies about commonly used antibiotics may harm your heart health and results showing that one daily combo pill may help lower blood pressure, heart disease risk.
The study was presented at the American Heart Association’s Scientific Sessions. One author of the study is Michael Levin, MD.
Copyright © 2021 Knowridge Science Report. All rights reserved.
